Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur
by
Kidder, Louis S.
, Lew, William D.
, Chen, Xinqian
in
Animals
/ Bone Morphogenetic Protein 7
/ Bone Morphogenetic Proteins - pharmacology
/ Femoral Fractures - drug therapy
/ Femoral Fractures - microbiology
/ Femur - physiology
/ Male
/ Osteitis - drug therapy
/ Osteitis - microbiology
/ Osteogenesis - drug effects
/ Rats
/ Rats, Sprague-Dawley
/ Staphylococcal Infections - complications
/ Transforming Growth Factor beta
2002
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur
by
Kidder, Louis S.
, Lew, William D.
, Chen, Xinqian
in
Animals
/ Bone Morphogenetic Protein 7
/ Bone Morphogenetic Proteins - pharmacology
/ Femoral Fractures - drug therapy
/ Femoral Fractures - microbiology
/ Femur - physiology
/ Male
/ Osteitis - drug therapy
/ Osteitis - microbiology
/ Osteogenesis - drug effects
/ Rats
/ Rats, Sprague-Dawley
/ Staphylococcal Infections - complications
/ Transforming Growth Factor beta
2002
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur
by
Kidder, Louis S.
, Lew, William D.
, Chen, Xinqian
in
Animals
/ Bone Morphogenetic Protein 7
/ Bone Morphogenetic Proteins - pharmacology
/ Femoral Fractures - drug therapy
/ Femoral Fractures - microbiology
/ Femur - physiology
/ Male
/ Osteitis - drug therapy
/ Osteitis - microbiology
/ Osteogenesis - drug effects
/ Rats
/ Rats, Sprague-Dawley
/ Staphylococcal Infections - complications
/ Transforming Growth Factor beta
2002
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur
Journal Article
Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur
2002
Request Book From Autostore
and Choose the Collection Method
Overview
The goal of this study was to use a segmental defect model in the rat femur to determine if osteogenic protein-1 (OP-1) is capable of inducing bone formation in the presence of bacterial contamination. A 6 mm segmental defect was surgically created and stabilized with a polyacetyl plate and Kirschner wires in one femur in each of 126 Sprague–Dawley rats. The animals were divided into eight groups in which the defect was either left untreated, or subjected to various combinations of OP-1 (11 or 50 μg), lyophilized bovine type I collagen (carrier for the OP-1), and 10
5 colony-forming units of
Staphylococcus aureus. The animals were euthanized at either 2, 4, or 9 weeks. Quantitative radiographic and histologic analyses were performed on the harvested tissue. The initial contamination progressed to infection in all animals receiving bacteria, as determined by qualitative bacteriology. There was very little, if any, bone formation in the untreated defects, and in the contaminated defects with or without collagen carrier. Bone formation was significantly greater in contaminated defects with either dose of OP-1, compared with contaminated defects without OP-1. The 50 μg dose of OP-1 induced significantly more bone formation than the 11 μg dose, both with and without bacteria. This investigation has demonstrated that OP-1 maintains its osteoinductive capability in a contaminated segmental defect. OP-1 may potentially be used in the clinical management of contaminated fractures.
Publisher
Elsevier Ltd,Wiley Subscription Services, Inc., A Wiley Company,Blackwell Publishing Ltd
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.